Nintedanib Impurity 67, with the CAS number 59276-32-3, is a chemical compound that is recognized as an impurity associated with the pharmaceutical agent Nintedanib, which is primarily used in the treatment of certain types of cancer and pulmonary diseases. While specific details about its physical and chemical properties may not be widely documented, impurities like this one are typically characterized by their molecular structure, stability, and potential reactivity. Such impurities can arise during the synthesis of the parent compound and may affect the purity and efficacy of the final pharmaceutical product. In the context of drug development and manufacturing, understanding the characteristics of impurities is crucial for ensuring safety, efficacy, and compliance with regulatory standards. Analytical techniques such as chromatography and mass spectrometry are often employed to identify and quantify impurities like Nintedanib Impurity 67, which helps in assessing their impact on the overall quality of the drug formulation.

Nintedanib Impurity 67

59276-32-3: Nintedanib Impurity 67, with the CAS number 59276-32-3, is a chemical compound that is recognized as an impurity associated with the pharmaceutical agent Nintedanib, which is primarily used in the treatment of certain types of cancer and pulmonary diseases. While specific details about its physical and chemical properties may not be widely documented, impurities like this one are typically characterized by their molecular structure, stability, and potential reactivity. Such impurities can arise during the synthesis of the parent compound and may affect the purity and efficacy of the final pharmaceutical product. In the context of drug development and manufacturing, understanding the characteristics of impurities is crucial for ensuring safety, efficacy, and compliance with regulatory standards. Analytical techniques such as chromatography and mass spectrometry are often employed to identify and quantify impurities like Nintedanib Impurity 67, which helps in assessing their impact on the overall quality of the drug formulation.

CAS 59276-32-3

Nintedanib Impurity 67

2,3-Dimethoxybenzaldehyde dimethylacetal

Ref: 4Z-B-085029